Continuous glucose monitors (CGMs), insulin pumps and insulin pump consumables: Procurement status
Find the latest information on Pharmac’s procurement process for continuous glucose monitoring (CGM) devices, insulin pumps and insulin pump consumables.
Request for Proposals released
On 11 July 2023, we announced our request for proposals (RFP) to fund CGMs, insulin pumps and consumables. Suppliers can now send Pharmac proposals responding to what we have asked for. The RFP is now closed.
For many of the 17,000 New Zealanders living with type 1 diabetes having funded access to these devices would be life changing. We are really pleased to be at the stage where we can consider funding CGMs, thanks to receiving our largest budget increase in 2022
As with all commercial processes, there is some uncertainty. The outcome depends on what bids we receive from suppliers. However, we think funding CGMs will be possible.
Advice from the experts
We consulted our Diabetes Specialist Advisory Committee. They have provided a range of advice on everything we need to consider when evaluating RFP bids from suppliers.
What happens after the RFP closes?
Once the RFP closes an evaluation committee, including Pharmac staff, clinical experts, and consumer representatives will meet to consider the proposals received.
Pharmac will use information gathered during the evaluation, alongside the Factors for Consideration, to select the preferred suppliers. At this stage we will continue with the usual funding process and consult with the public, giving all New Zealanders a chance to give feedback.
We will carefully consider all consultation feedback and make any necessary changes to what we are proposing to fund. The Pharmac Board will then consider all consultation feedback along with the proposal and decide on the outcome.
Once a decision is made, our team will ensure there are measures in place to support any changes that result from this process. For example, organising education resources that outline next steps for clinicians and consumers.
How long will it take?
Pharmac understands people would like to know how long this procurement process will take. We are working to the following milestones and will update this page if there are changes.
|FPO release||Complete (Feb 2023)|
|Clinical advice||Complete (April 2023)|
Publishing records of clinical advice from the diabetes Specialist Advisory Committe
|Complete (July 2023)|
|RFP release||Complete (July 2023)|
|Supplier briefing||Complete (July 2023)|
|Stakeholder briefing||Complete (August 2023)|
|Bids close||Complete (August 2023)|
|Evaluation committee meetings and seeking further clinical advice||September 2023|
|Pharmac Board meeting||TBD|
|Decision notification date||TBD|
|Provisional implementation date||TBD 2024|
Who to contact
We will update this page as more information becomes available.
If your question is not answered here, email firstname.lastname@example.org